Author: Elaine A. Moore
Edition:
Binding: Paperback
ISBN: 0786437154
Edition:
Binding: Paperback
ISBN: 0786437154
The Promise Of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders
Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson's disease and amyotrophic lateral sclerosis (ALS). Grounded in clinical and scientific research, this book describes the history of naltrexone, its potential therapeutic uses, its effects on the immune system, its pharmacological properties, and how the drug is administered. It also lists author elaine a moore author samantha wilkinson format paperback language english publication year 15 02 2009 subject medicine subject 2 clinical medicine professional title the promise of low dose naltrexone therapy potential benefits in cancer autoimmune neurological and infectious disorders author moore elaine a wilkinson samantha agrawal yash pal md ph d foreward by publisher mcfarland co inc pub publication date nov 01 2008 pages 213 binding paperback dimensions 6 25 wx 9 25 hx 0 75 d is Read medical textbooks online like The Promise Of Low Dose Naltrexone Therapy here
The Promise of Low Dose Naltrexone Therapy
The Promise of Low Dose Naltrexone Therapy
The Promise of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders, ISBN-13: 9780786437153, ISBN-10: 0786437154
Buy The Promise of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders by Elaine A. Moore and Samantha Wilkinson and Read this Book on Kobo's Free Apps. Discover Kobo's Vast Collection of Ebooks Today - Over 3 Million Titles, Including 2 Million Free Ones!
author elaine a moore author samantha wilkinson format paperback language english publication year 15 02 2009 subject medicine subject 2 clinical medicine professional title the promise of low dose naltrexone therapy potential benefits in cancer autoimmune neurological and infectious disorders author moore elaine a wilkinson samantha agrawal yash pal md ph d foreward by publisher mcfarland co inc pub publication date nov 01 2008 pages 213 binding paperback dimensions 6 25 wx 9 25 hx 0 75 d is
The Promise Of Low Dose Naltrexone Therapy Online
When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson's disease and amyotrophic lateral sclerosis (ALS)
It also lists
